Article

Validation of in vitro and in vivo personalized cancer treatment assays for head and neck squamous cell carcinoma

2022-12-12

Abstract excerpt

<h4>Background: </h4> Head and neck squamous cell carcinoma (HNSCC) is a common cancer with a high heterogeneity and few approved treatments. HNSCC is one of the least explored areas for precision oncology. In this study, we aimed to test the reliability of our three established rapid cancer systemic treatment-testing assays: human tumor-derived matrix (Myogel)-coated well-plates, zebrafish xenografts, and 3D micr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 77e89105-19f7-5015-a929-806a188e0aa1
DOI: 10.21203/rs.3.rs-2357747/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Validation of in vitro and in vivo personalized cancer treatment assays for head and neck squamous cell carcinomaDOI 10.21203/rs.3.rs-2357747/v1Read

Phenotype-driven precision oncology as a guide for clinical decisions one patient at a time.Semantic proximity Read

Development of a Circulating Tumour Cell Culture Model from Head and Neck Squamous Cell CarcinomaSemantic proximity Read

Head and neck cancer patient-derived tumouroid cultures: opportunities and challengesSemantic proximity Read

Predicting Head and Neck Squamous Cell Carcinoma outcomes using long-term Patient-Derived Tumor OrganoidsSemantic proximity Read

Integrated computational screening and liquid biopsy approach to uncover the role of biomarkers for oral cancer lymph node metastasisSemantic proximity Read

Analytical performance of OncoPrism-HNSCC, an RNA-based assay to inform immune checkpoint inhibitor treatment decisions for recurrent/metastatic head and neck squamous cell carcinomaSemantic proximity Read

Genomics and precision surgery for head and neck squamous cell carcinomaSemantic proximity Read

PATIENT-DERIVED ORGANOIDS CAPTURE HISTOLOGICAL, MOLECULAR AND THERAPEUTIC HETEROGENEITY IN PHARYNGEAL AND LARYNGEAL SQUAMOUS CELL CARCINOMASSemantic proximity Read

Tumour informed workflow to use ctDNA as a biomarker for risk of recurrence in head and neck cancer patients post-treatmentSemantic proximity Read

Integrating Artificial Intelligence-Driven Digital Pathology and Genomics to Establish Patient-Derived Organoids as a Novel Alternative Model for Drug Response in Head and Neck CancerSemantic proximity Read

Patient-derived esophageal adenocarcinoma organ chip: a physiologically relevant platform for functional precision oncologySemantic proximity Read

Establishment of a Large-Scale PDX Library of Head and Neck Cancers for Functional Precision Oncology.Semantic proximity Read